Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ascendance Biotechnology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10546
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits, dog HepatoPac kits, and multi-species HepatoPac kits. It also provides vitro micro-liver cell-based platforms for use in pharmaceutical, safety testing, biotherapeutic and diagnostic product development. Ascendance’ products are created using cell micropatterning technology that plates different cell patterns on industry-standard microwell plates. The company’s products find applications in metabolite identification, preclinical toxicity screening, metabolic stability, transporter-mediated drug uptake and biliary efflux, drug-drug interactions and efficacy assessment. Ascendance is headquartered in Medford, Massachusetts, the US.

Ascendance Biotechnology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ascendance Biotechnology Raises USD0.2 Million in Financing 11
Partnerships 12
BioTime and Hepregen Form Joint Venture 12
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 13
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 14
Hepregen Enters Into R&D Agreement With Hamner Institutes 15
Licensing Agreements 16
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
Acquisition 17
BioIVT Acquires Ascendance Biotech 17
Ascendance Biotechnology Inc – Key Competitors 18
Ascendance Biotechnology Inc – Key Employees 19
Ascendance Biotechnology Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ascendance Biotechnology Raises USD0.2 Million in Financing 11
BioTime and Hepregen Form Joint Venture 12
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 13
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 14
Hepregen Enters Into R&D Agreement With Hamner Institutes 15
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
BioIVT Acquires Ascendance Biotech 17
Ascendance Biotechnology Inc, Key Competitors 18
Ascendance Biotechnology Inc, Key Employees 19
Ascendance Biotechnology Inc, Other Locations 20

List of Figures
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioanalytical Systems, Inc.:企業の戦略・SWOT・財務情報
    Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Carlsberg AS (CARL B):企業の財務・戦略的SWOT分析
    Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AIG Japan Holdings Kabushiki Kaisha:企業の戦略・SWOT・財務分析
    AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Toshiba Corp (6502):企業の財務・戦略的SWOT分析
    Toshiba Corp (6502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Citic Resources Holdings Limited:企業の戦略・SWOT・財務分析
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • BioScrip Inc (BIOS):医療機器:M&Aディール及び事業提携情報
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that provides infusion care services. The hospital offers a range of infusion services, PBM services and respiratory services. It provides infusion therapy services such as antimicrobial drugs, factor replacement the …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Henry Ford Health System:企業の戦略的SWOT分析
    Henry Ford Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Shionogi & Co., Ltd.:企業の戦略・SWOT・財務分析
    Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • New Image Group Ltd:企業の戦略的SWOT分析
    New Image Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Covanta Holding Corporation:企業の戦略・SWOT・財務分析
    Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • UniCredit S.p.A:戦略・SWOT・企業財務分析
    UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report Summary UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Development Financial Holding Corporation:企業の戦略・SWOT・財務情報
    China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Galaxy Entertainment Group Ltd
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Virginia Electric and Power Co:企業の戦略的SWOT分析
    Virginia Electric and Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆